These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 8731094
1. Intragraft TGF-beta 1 mRNA: a correlate of interstitial fibrosis and chronic allograft nephropathy. Sharma VK, Bologa RM, Xu GP, Li B, Mouradian J, Wang J, Serur D, Rao V, Suthanthiran M. Kidney Int; 1996 May; 49(5):1297-303. PubMed ID: 8731094 [Abstract] [Full Text] [Related]
2. Molecular analyses of human renal allografts: differential intragraft gene expression during rejection. Suthanthiran M. Kidney Int Suppl; 1997 Mar; 58():S15-21. PubMed ID: 9067937 [Abstract] [Full Text] [Related]
4. Clinical application of molecular biology: a study of allograft rejection with polymerase chain reaction. Suthanthiran M. Am J Med Sci; 1997 May; 313(5):264-7. PubMed ID: 9145034 [Abstract] [Full Text] [Related]
14. [Role of transforming growth factor beta-1 gene polymorphisms in the development of chronic allograft nephropathy in renal transplant recipients]. Iñigo P, Lario S, Campistol JM, Bescós M, Campos B, Oppenheimer F. Nefrologia; 2003 Feb 15; 23(4):312-20. PubMed ID: 14558330 [Abstract] [Full Text] [Related]
15. Renal transplant fibrosis correlates with intragraft expression of tissue inhibitor of metalloproteinase messenger RNA. Nicholson ML, Waller JR, Bicknell GR. Br J Surg; 2002 Jul 15; 89(7):933-7. PubMed ID: 12081746 [Abstract] [Full Text] [Related]
16. Molecular diagnosis of renal-allograft rejection: correlation with histopathologic evaluation and antirejection-therapy resistance. Desvaux D, Schwarzinger M, Pastural M, Baron C, Abtahi M, Berrehar F, Lim A, Lang P, le Gouvello S. Transplantation; 2004 Sep 15; 78(5):647-53. PubMed ID: 15371663 [Abstract] [Full Text] [Related]
17. Protease-activated receptor 1 and plasminogen activator inhibitor 1 expression in chronic allograft nephropathy: the role of coagulation and fibrinolysis in renal graft fibrosis. Grandaliano G, Di Paolo S, Monno R, Stallone G, Ranieri E, Pontrelli P, Gesualdo L, Schena FP. Transplantation; 2001 Oct 27; 72(8):1437-43. PubMed ID: 11685117 [Abstract] [Full Text] [Related]
18. Unmodified pancreatic islet allograft rejection results in the preferential expression of certain T cell activation transcripts. O'Connell PJ, Pacheco-Silva A, Nickerson PW, Muggia RA, Bastos M, Kelley VR, Strom TB. J Immunol; 1993 Feb 01; 150(3):1093-104. PubMed ID: 8423334 [Abstract] [Full Text] [Related]
19. Type 2 angiotensin II receptor expression in human renal allografts: an association with chronic allograft nephropathy. Becker BN, Jacobson LM, Hullett DA, Radke NA, Oberley TD, Brazy PC, Kirk AD. Clin Nephrol; 2002 Jan 01; 57(1):19-26. PubMed ID: 11837798 [Abstract] [Full Text] [Related]
20. [Gene expression of INF-gamma, IL-10, IL-2, IL-6, PDGF-B i TGF-beta in kidney tissue after renal transplantation]. Kamińrska D, Tyran B, Mazanowska O, Rabczyński J, Patrzałek D, Szyber P, Chudoba P, Klinger M. Pol Merkur Lekarski; 2006 Aug 01; 21(122):148-50; discussion 151. PubMed ID: 17144099 [Abstract] [Full Text] [Related] Page: [Next] [New Search]